|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/02/20 Magellan Health Inc 8-K:8 6/02/20 10:143K Toppan Merrill Bridge/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 30K 9: R1 Document and Entity Information HTML 47K 6: XML IDEA XML File -- Filing Summary XML 11K 10: XML XBRL Instance -- mgln-20200602x8k_htm XML 15K 7: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.LAB XBRL Labels -- mgln-20200602_lab XML 44K 4: EX-101.PRE XBRL Presentations -- mgln-20200602_pre XML 31K 2: EX-101.SCH XBRL Schema -- mgln-20200602 XSD 13K 8: JSON XBRL Instance as JSON Data -- MetaLinks 11± 17K 5: ZIP XBRL Zipped Folder -- 0001558370-20-007204-xbrl Zip 9K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM i 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
MAGELLAN HEALTH, INC.
(Exact Name of Registrant as Specified in Charter)
| | |
i Delaware | i 1-6639 | i 58-1076937 |
(State or Other Jurisdiction | (Commission File | (IRS Employer |
of Incorporation) | Number) | Identification No.) |
| |
i 4801 E. Washington Street | |
i Phoenix, i Arizona | i 85034 |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: ( i 800) i 642-1716
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
i Common Stock, par value $0.01 per share | i MGLN | i The NASDAQ Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events
On June 2, 2020, Steven J. Shulman, Chairman of the Board of Directors (the “Board”) of Magellan Health, Inc., voluntarily resigned from the Nominating/Corporate Governance Committee of the Board, effective immediately. Following such resignation, Mr. Shulman will continue to serve as Chairman of the Board.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MAGELLAN HEALTH, INC.
| | | |
Date: June 2, 2020 | By: | ||
| | Name: Jonathan N. Rubin | |
| | Title: Chief Financial Officer | |
3
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 6/2/20 | DEFA14A | ||
| List all Filings | ||||